ABSTRACTS
Оral presentations, awarded posters:
1. SYNTHETIC DATA IN EVIDENCING HYPOTHESIS FOR GRANT APPLICATION TO COLLECT LARGE DATASET OF ROUTINE HEMATOLOGY TESTING:A CALL FOR NEW NARRATIVE- Rana Zeeshan Haider
2. THE IMPACT OF NGS-BASED MINIMAL RESIDUAL DISEASE LEVEL ON CLINICAL OUTCOME IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA- Krstevska Bozhinovikj Elizabeta
3. MOLECULAR PROFILING OF PATIENTS WITH PHILADELPHIA CHROMOSOME-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS (PH- MPN) FROM RN MACEDONIA- Marija Popova-Labachevska, Marija Staninova-Stojovska
4. DISCONTINUATION OF IMATINIB TREATMENT IN PATIENTS WITH CML IN PATIENT WITH DEEP MOLECULAR RESPONSE–SINGLE CENTRE EXPERIENCE- Pavkovic Marica
- A CASE REPORT OF ACQUIRED HAEMOPHILIA WITH MASSIVE SKIN AND MUSCLE BLEEDING
- A PREDICTIVE INSTRUMENT FOR PROBABILITY OF TREATMENT AT PATIENTS WITH ASYMPTOMATIC EARLY-STAGE CHRONIC LYMPHOCYTIC LEUKEMIA
- A RARE CASE OF INFANTILE GENITAL HEMANGIOMA
- ACQUIRED HEMOPHILIA A AND SYSTEMIC CONNECTIVE TISSUE DISEASE
- AUTOIMMUNE CYTOPENIAS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA SINGLE CENTER EXPERIENCE
- CLINICAL BENEFITS OF ROPEGINTERFERON ALFA-2B IN THE TREATMENT OF YOUNG HIGH-RISK PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA SINGLE CENTER EXPERIENCE
- CLINICAL FEATURES AND OUTCOMES IN NEWLY DIAGNOSED PAEDIATRIC IMMUNE THROMBOCYTOPENIA
- CLINICAL PRESENTATION AND OUTCOMES OF PAEDIATRIC AUTOIMMUNE HEMOLYTIC ANEMIA
- CLINICALLY SIGNIFICANT DRUG INTERACTIONS OF ELTROMBOPAG
- DISCONTINUATION OF IMATINIB TREATMENT IN PATIENTS WITH CML IN PATIENT WITH DEEP MOLECULAR RESPONSE
- EVALUATION OF IMMUNOLOGICAL CHANGES IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA DURING CHEMOTHERAPY
- EXPERIENCE OF THE DIAGNOSIS AND TREATMENT OF VISCERAL LEISCHMANIASIS IN PEDIATRIC POPULATION AT UNIVERSITY CLINIC FOR CHILDREN’S DISEASES
- EXTRACORPOREAL PHOTOPHERESIS FOR CHRONIC GvHD TREATMENT IN PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION
- GLANZMANN THROMBASTHENIA - A CASE REPORT OF RARE BLEEDING DISORDER
- HIGH-DOSE CHEMOTHERAPY REGIMENTS IN THERAPY OF NHL DLBCL
- HOW TO TREAT HISTIOCYTIC SARCOMA, A RARE MALIGNANT TUMOUR
- INFLUENCE OF SINGLE NUCLEOTIDE POLYMORPHISMS IN MTHFR GENES ON OCCURRENCE OF HAEMATOLOGICAL SIDE EFFECTS CAUSED BY MTX IN PATIENTS WITH RHEUMATOID ARTHRITIS
- INGUINAL AND RETROPERITONEAL LYMPHADENOPATHY AS INITIAL PRESENTATION OF ADVANCED PROSTATE CANCER MIMICKING LYMPHOMA
- MAINTENANCE THERAPY FOR MULTIPLE MYELOMA HOW LONG TO TREAT
- MOLECULAR PROFILING OF PATIENTS WITH PHILADELPHIA CHROMOSOME-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS (PH- MPN) FROM RN MACEDONIA
- MRD MONITORING OF PHILADELPHIA CHROMOSOME-POSITIVE B ALL PATIENTS IN NORTH MACEDONIA - SINGLE CENTRE EXPERIENCE
- PEGINTERFERON ALFA-2A FOR THE TREATMENT OF PAEDIATRIC ESSENTIAL THROMBOCYTHEMIA
- PREGNANCY RELATED ACQUIRED HAEMOPHILIA A- CASE REPORT
- PROGNOSTIC FACTORS FOR OVERALL SURVIVAL IN PEDIATRIC PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
- QUALITY OF LIFE IN PATIENTS TREATED WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
- SEVERE GASTROINTESTINAL PRESENTATION OF HENOCH-SCHÖNLEIN PURPURA WITH DECREASED FACTOR XIII ACTIVITY (2)
- SMALL BOWEL PERFORATION IN PATIENT WITH ACUTE MYELOID LEKEMIA
- SORAFENIB WITH ATRA PLUS CHEMOTHERAPY IN HIGH RISK FLT 3 POSITIVE APL
- SUCCESSFUL TREATMENT WITH BRENTUXIMAB VEDOTIN AS FIRST-LINE AGENT FOR ADVANCED HODGKIN LYMPHOMA
- SYNTHETIC DATA IN EVIDENCING HYPOTHESIS FOR GRANT APPLICATION TO COLLECT LARGE DATASET OF ROUTINE HEMATOLOGY TESTING
- Severe COVID-19 pneumonia in a child with acute lymphoblastic leukemia
- THE ADDITION OF FLT3 INHIBITOR TO STANDARD INDUCTION CHEMOTHERAPY INCREASES THE RATES OF COMPLETE REMISSIONS IN FLT3
- THE IMPACT OF NGS-BASED MINIMAL RESIDUAL DISEASE LEVEL ON CLINICAL OUTCOME IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
- The influence of RFC1 A80G gene polymorphisms on Methotrexate Toxicity in Pediatric Acute Lymphoblastic Leukemia
- МANAGEMENT OF CYTOMEGALOVIRUS REACTIVATION IN ACUTE LEUKEMIA PATIENTS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
General sponsor:
Gold sponsors:
Other sponsors:
